Integrating Molecular Analysis into the Pathologic Evaluation of Pancreatic Cysts.
Intraductal papillary mucinous neoplasm
Mucinous cystic neoplasm
Pancreatic cystic lesion
Serous cystadenoma
Journal
Surgical pathology clinics
ISSN: 1875-9157
Titre abrégé: Surg Pathol Clin
Pays: United States
ID NLM: 101491209
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
entrez:
1
9
2022
pubmed:
2
9
2022
medline:
8
9
2022
Statut:
ppublish
Résumé
The development of cross-sectional imaging techniques has enhanced the detection of pancreatic cystic lesions (PCLs). PCLs are found in approximately 2% of the general population, often as incidentally detected lesions on computed tomography or MRI during the evaluation of other medical conditions. Broadly, PCLs are classified as mucinous or nonmucinous. Mucinous PCLs include mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Nonmucinous PCLs include pseudocysts, serous cystadenomas, solid pseudopapillary neoplasms, and cystic pancreatic neuroendocrine tumors, as well as cystic acinar cell carcinoma, cystic degeneration of pancreatic ductal adenocarcinoma, lymphoepithelial cyst, and others.
Identifiants
pubmed: 36049828
pii: S1875-9181(22)00045-9
doi: 10.1016/j.path.2022.05.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
455-468Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.